FTFinancial Times·2hBusiness
score-0.20
Oxford BioMedica leaves door open to private equity takeover
Original
Oxford BioMedica leaves door open to private equity takeover
“Neutral reporting on M&A activity with mild openness framing; rejected offers and selectivity suggest cautious positioning rather than alarm.”